Shasqi

Chemistry
#Cancer research #Click chemistry #Johnson & Johnson #Oncology #Partnership #Shasqi

Partners will use click chemistry to create targeted cancer therapies

Biotech company Shasqi and Johnson & Johnson have entered into a research collaboration to develop new cancer therapies. Shasqi’s Click Activated Protodrugs Against Cancer (CAPAC) platform relies on chemistry for activation of drugs at the tumour. The platform is made up of a tumour-targeting agent and… Read More

#Cancer Research #News